LONDON - Three former Shire Pharmaceuticals Group plc executives have raised $7.1 million to acquire nasal drug delivery technology from West Pharmaceutical Services Inc. (WPS), along with $40 million for product development, as the foundation of a new company, Archimedes Pharma Ltd. (BioWorld International) Read More
